कवर छवि

Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and <i>Pseudomonas aeruginosa</i> from Intensive Care Unit and Non-Intensive Care Unit Patients

We evaluated the activities of aztreonam/avibactam and recently approved β-lactamase inhibitor combinations (BLICs) to compare the antimicrobial susceptibility patterns of Enterobacterales and <i>Pseudomonas aeruginosa</i> isolated from intensive care unit (ICU) and non-ICU patients. Cli...

पूर्ण विवरण

में बचाया:

ग्रंथसूची विवरण
मुख्य लेखकों:	Helio S. Sader (लेखक), Rodrigo E. Mendes (लेखक), John H. Kimbrough (लेखक), Cory M. Hubler (लेखक), Mariana Castanheira (लेखक)
स्वरूप:	पुस्तक
प्रकाशित:	MDPI AG, 2024-06-01T00:00:00Z.
विषय:	article
ऑनलाइन पहुंच:	Connect to this object online.
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन

In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant <i>Enterobacterales</i> Isolates from South Korea
द्वारा: Taeeun Kim, और अन्य
प्रकाशित: (2020)

Aztreonam Combinations with Avibactam, Relebactam, and Vaborbactam as Treatment for New Delhi Metallo-β-Lactamase-Producing Enterobacterales Infections-In Vitro Susceptibility Testing
द्वारा: Małgorzata Brauncajs, और अन्य
प्रकाशित: (2024)

In Vitro Susceptibility of Aztreonam-Vaborbactam, Aztreonam-Relebactam and Aztreonam-Avibactam Associations against Metallo-β-Lactamase-Producing Gram-Negative Bacteria
द्वारा: Cécile Emeraud, और अन्य
प्रकाशित: (2023)

In Vitro Activities of Ceftazidime-Avibactam and Aztreonam-Avibactam at Different Inoculum Sizes of Extended-Spectrum β-Lactam-Resistant Enterobacterales Blood Isolates
द्वारा: Moonsuk Bae, और अन्य
प्रकाशित: (2021)

Impact of an intervention that decreased aztreonam DOT on Enterobacterales' susceptibility to aztreonam
द्वारा: Jose G Castro, और अन्य
प्रकाशित: (2024)

Use of Ceftazidime-Avibactam in Children Admitted to Pediatric Intensive Care Units
द्वारा: André Ricardo Araujo da Silva, और अन्य
प्रकाशित: (2024)

Evaluation of Aztreonam and Ceftazidime/Avibactam Synergism against <i>Klebsiella pneumoniae</i> by MALDI-TOF MS
द्वारा: Camila Mörschbächer Wilhelm, और अन्य
प्रकाशित: (2023)

Practical Application of Aztreonam-Avibactam as a Treatment Strategy for Ambler Class B Metallo-β-Lactamase Producing Enterobacteriaceae
द्वारा: Darren W. Wong
प्रकाशित: (2024)

Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope
द्वारा: Rawan Taha, और अन्य
प्रकाशित: (2023)

The Use of Ceftazidime-Avibactam in a Pediatric Intensive Care Unit-An Observational Prospective Study
द्वारा: Raquel García Romero, और अन्य
प्रकाशित: (2024)

Correction: Ceftazidime-Avibactam plus aztreonam synergistic combination tested against carbapenem-resistant Enterobacterales characterized phenotypically and genotypically: a glimmer of hope
द्वारा: Rawan Taha, और अन्य
प्रकाशित: (2023)

Risk Factors for Carbapenemase-Producing <i>Enterobacterales</i> Infection or Colonization in a Korean Intensive Care Unit: A Case-Control Study
द्वारा: Young Ah Kim, और अन्य
प्रकाशित: (2020)

Resistance to aztreonam-avibactam due to a mutation of SHV-12 in Enterobacter
द्वारा: Shikai Wu, और अन्य
प्रकाशित: (2023)

The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases
द्वारा: Carola Mauri, और अन्य
प्रकाशित: (2021)

Colonization of Extended-spectrum β-lactamase producing Enterobacterales and meticillin-resistant S. aureus in the intensive care unit at a tertiary hospital in Tanzania: Implications for Infection control and prevention
द्वारा: Joel Manyahi, और अन्य
प्रकाशित: (2022)

In Vitro Activity of Aztreonam-avibactam and Ceftazidime-avibactam against Pseudomonas aeruginosa Collected in a Global Surveillance Program in the Africa/Middle East, 2014-2017
द्वारा: I Morrissey, और अन्य
प्रकाशित: (2020)

Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Enterobacterales Analyzed by ICU and Non-ICU Wards, Infection Sources, and Geographic Regions: ATLAS Program 2016-2020
द्वारा: Denis Piérard, और अन्य
प्रकाशित: (2023)

Synergistic Combination of Aztreonam and Ceftazidime-Avibactam-A Promising Defense Strategy against OXA-48 + NDM <i>Klebsiella pneumoniae</i> in Romania
द्वारा: Ioana Miriana Cismaru, और अन्य
प्रकाशित: (2024)

Effectiveness of empiric carbapenem versus non-carbapenem therapy for extended-spectrum β-lactamase producing Enterobacterales infections in non-intensive care unit patients: a real-world investigation in a hospital with high-prevalence of extended-spectrum β-lactamase producing Enterobacterales
द्वारा: Amy Y. Kang, और अन्य
प्रकाशित: (2024)

Carbapenem-resistant Enterobacterales colonization and subsequent infection in a neonatal intensive care unit in Shanghai, China
द्वारा: L. Yin, और अन्य
प्रकाशित: (2021)

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
द्वारा: Wei Yu, और अन्य
प्रकाशित: (2021)

β-lactamase-producing Gram-negative bacteria in an intensive care unit in southern Brazil
द्वारा: Clariana Akemi Kariya Leite, और अन्य
प्रकाशित: (2017)

Successful Control of an Outbreak by Phenotypically Identified Extended-Spectrum Beta-Lactamase-Producing <i>Klebsiella pneumoniae</i> in a Neonatal Intensive Care Unit
द्वारा: Elena Priante, और अन्य
प्रकाशित: (2022)

Dosing Evaluation of Ceftazidime-Avibactam in Intensive Care Unit Patients Based on Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling and Simulation
द्वारा: Hinojal Zazo, और अन्य
प्रकाशित: (2024)

Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant <i>Klebsiella pneumonia</i>
द्वारा: Konstantinos Mantzarlis, और अन्य
प्रकाशित: (2024)

Potentiation of Antibiotic Activity of Aztreonam against Metallo-β-Lactamase-Producing Multidrug-Resistant <i>Pseudomonas aeruginosa</i> by 3-<i>O</i>-Substituted Difluoroquercetin Derivatives
द्वारा: Seongyeon Lee, और अन्य
प्रकाशित: (2024)

Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of <i>Enterobacterales</i> and <i>Pseudomonas aeruginosa</i>
द्वारा: Arhodoula Papadomanolaki, और अन्य
प्रकाशित: (2022)

Nosocomial cross-transmission of <i>Pseudomonas aeruginosa</i> between patients in a tertiary intensive care unit
द्वारा: Dwivedi M, और अन्य
प्रकाशित: (2009)

Detection of Different Types of Metallo-β-Lactamases among Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients
द्वारा: Farzin Khorvash, और अन्य
प्रकाशित: (2014)

Extended-Spectrum Beta-Lactamase Producing Enterobacterales Infections in the United States, 2012-2021
द्वारा: Alexander Maillis, और अन्य
प्रकाशित: (2024)

The <i>Klebsiella pneumoniae</i> carbapenemase (KPC) β-Lactamase Has Evolved in Response to Ceftazidime Avibactam
द्वारा: Sona Garsevanyan, और अन्य
प्रकाशित: (2023)

COVID-19 and <i>Clostridioides difficile</i> Coinfection Analysis in the Intensive Care Unit
द्वारा: Mircea Stoian, और अन्य
प्रकाशित: (2024)

<i>Pseudomonas aeruginosa</i> Infections in Patients with Severe COVID-19 in Intensive Care Units: A Retrospective Study
द्वारा: Alexandre Baudet, और अन्य
प्रकाशित: (2024)

A Literature Overview of Secondary Peritonitis Due to Carbapenem-Resistant Enterobacterales (CRE) in Intensive Care Unit (ICU) Patients
द्वारा: Sveva Di Franco, और अन्य
प्रकाशित: (2022)

Susceptibility of Meropenem-Resistant and/or Carbapenemase-Producing Clinical Isolates of <i>Enterobacterales</i> (<i>Enterobacteriaceae</i>) and <i>Pseudomonas aeruginosa</i> to Ceftazidime-Avibactam and Ceftolozane-Tazobactam as Assessed by In Vitro Testing Methods
द्वारा: Venere Cortazzo, और अन्य
प्रकाशित: (2022)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing <i>Enterobacterales</i> and Differentiation of Carbapenem-Resistant <i>Enterobacterales</i>
द्वारा: Kentarou Takei, और अन्य
प्रकाशित: (2023)

Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-β-Lactamase and Serine-β-Lactamase Co-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>
द्वारा: Jiayuan Zhang, और अन्य
प्रकाशित: (2023)

Dermatology in the Intensive Care Unit
द्वारा: Uwe Wollina, और अन्य
प्रकाशित: (2012)

Probiotics in the Intensive Care Unit
द्वारा: Alex R. Schuurman, और अन्य
प्रकाशित: (2022)

The physiotherapist in an Intensive Care Unit
द्वारा: C. J. Mieny
प्रकाशित: (1970)